Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production.

Nicholas James CampionAnna DoraltChristian LupinekMarkus BergerKatharina PoglitschJonas BruggerTamara QuintKatharina GanglChristoph SinzTina BartosikDavid Tianxiang LiuLukas David LandeggerAldine TuVictoria StanekUwe BergerChristine BangertSven SchneiderJulia Eckl-Dorna

Published in: Allergy (2023)

Keyphrases

allergic rhinitis
atopic dermatitis
signaling pathway
risk factors
patient reported